The follow-up of patients with cervical lymphatic venostomy (LVA) performed by Professor Xie Qingping's team for more than two years was published

As the pioneer of cervical lymphatic venostomy, Professor Xie Qingping of our hospital has carried out relevant surgical research to improve the functional symptoms of Alzheimer's patients since 2018, and more than 200 patients have received the surgery so far. Some patients showed satisfactory improvement in their quality of life in the near and long term after surgery. Two patients with cervical lymphatic venostomy who had been operated by Professor Xie Qingping for more than 2 years were followed up.

Professor Xie Qingping from Qiushi Hospital of Hangzhou attended the 2nd Annual Conference of Rare Diseases of Chinese Medical Association and made a special academic sharing

From October 11 to 13, 2024, the 2nd Annual Conference on Rare Diseases of the Chinese Medical Association was successfully held at the Hangzhou International Expo Center. Professor Xie Qingping from Hangzhou Qiushi Hospital was invited to attend and share his academic insights.

9.21 World Alzheimer's Day Professor Qingping Xie: Alzheimer's Disease Health and Science

Alzhimer's dementia (AD) is a progressive degenerative neurological disorder with insidious onset. The clinical manifestations of generalized dementia are memory impairment, aphasia, apraxia, agnosia, visuospatial impairment, executive dysfunction, and personality and behavioral changes. The incidence of Alzheimer's disease has been increasing year by year, and it is a kind of disease that seriously affects the health of old people in our country. The epidemiological study of Alzheimer's disease in China found that from 2005 to 2015, the prevalence of Alzheimer's disease was about 5%, of which the most common is AD, accounting for 65% of Alzheimer's disease. At present, the prevalence rate of Alzheimer's disease in people over 65 years old in China is about 3.21%. So far, the cause of Alzheimer's disease is not well understood.

Pay attention to these 3 habits in middle age to help you stay away from Alzheimer's disease!

Alzheimer's disease (AD) is a disease with high social, family and economic burden caused by complex pathogenesis. We still have a long way to go to overcome this disease. Although Alzheimer's disease is difficult to beat, existing research results suggest that we can try to prevent it by improving lifestyle.

Two or Three Things You Should Know About Alzheimer's Disease: The New Drug - Lecanemab

On June 26, 2024, Lecanemab, a highly anticipated new drug for targeted treatment of Alzheimer's disease, was prescribed for the first time in China. This progress marks a new stage in the field of precision medicine for AD in China.

Professor Xie Qingping had an academic exchange with visiting experts from Singapore and the United States

On September 9th-13th, 2024, Professor Jeremy Sun's team from the Department of Surgery at Changi General Hospital in Singapore will come to our hospital to exchange and learn about the latest advances in improving AD symptoms through neck lymphatic venous anastomosis. During the same period, the Vice President of MMI Asia Pacific and the Vice President of Clinical Training and Education will also pay a visit.